Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas.
| Autor: | von Mehren, M.1 m_vonmehren@fccc.edu, Balcerzak, S. P.2, Kraft, A. S.3, Edmonson, J. H.4, Okuno, S. H.4, Davey, M.1, McLaughuns, S.1, Beard, M. T.1, Rogatko, A.5 |
|---|---|
| Zdroj: | Sarcoma. Dec2004, Vol. 8 Issue 4, p107-111. 5p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|